Heterogeneity of genomic evolution and mutational profiles in multiple myeloma

Bolli, Niccolo, Avet-Loiseau, Hervé, Wedge, David C., Van Loo, Peter, Alexandrov, Ludmil B., Martincorena, Inigo, Dawson, Kevin J., Iorio, Francesco +27 more·2014·Nature Communications
DOI 10.1038/ncomms3997

Cited by (875)

Items 701–800 of 875

  1. Genomic studies of multiple myeloma reveal an association between X chromosome alterations and genomic profile complexity
    Tiberio Sticca, Jean‐Hubert Caberg, Stéphane Wenric, Christophe Poulet, Christian Herens, Mauricette Jamar, Claire Josse, Sonia ElGuendi, Stéphanie Max, Yves P. Beguin et al. · 2016 · Genes Chromosomes and Cancer
  2. Dissecting the Biological Relevance and Clinical Impact of lncRNA MIAT in Multiple Myeloma
    Katia Todoerti, Domenica Ronchetti, Noemi Puccio, Ilaria Silvestris, Vanessa Katia Favasuli, Nicola Amodio, Massimo Gentile, Fortunato Morabito, Antonino Neri, Elisa Taìana · 2021 · Cancers
  3. Stratification of Patients with Multiple Myeloma: State-of-the-Art and Prospects
    Anna Yu. Aksenova, Anna S. Zhuk, Elena Igorevna Stepchenkova, Sergei Vasil'evich Gritsaev · 2022 · Clinical oncohematology
  4. Creation of a collection of blood samples of patients with multiple myeloma
    Надежда Владимировна Гненная, Софья Владимировна Тимофеева, A. О. Sitkovskaya, Inna Arnoldovna Novikova, Irina B. Lysenko, Камаева Инна Анатольевна, Oleg Ivanovich Kit · 2022 · CARDIOVASCULAR THERAPY AND PREVENTION
  5. Using genomics to better define high-risk MGUS/SMM patients
    Ankit K. Dutta, Duncan R. Hewett, J. Lynn Fink, Andrew C.W. Zannettino · 2018 · Oncotarget
  6. KRAS/NRAS Gene Mutations and the Efficacy of Bortezomib-Based Triplet Induction Therapy in Patients with Newly Diagnosed Multiple Myeloma
    Anna Sergeeva, В. Л. Сурин, Ю. А. Чабаева, А. А. Крайзман, Maksim Valerevich Solovev, Sergei M. Kulikov, Л. П. Менделеева · 2024 · Clinical oncohematology
  7. Comprehensive assessment of computational methods for cancer immunoediting
    Shengyuan He, Shangqin Sun, Kun Liu, Bo Pang, Yun Xiao · 2025 · Cell Reports Methods
  8. Impact of NRAS mutation on efficacy of triplet induction therapy in newly diagnosed multiple myeloma
    Yuko Matsumoto Mishima, Yuko Shirouchi, Tomoko Takayama, Sayuri Minowa, Yuko Ishihara, Kei Hirano, Mitsuhito Hirano, Kikuaki Yoshida, Yukako Teramoto, Nobuhiko Yamauchi et al. · 2025 · Journal of the Japan Society of the Reticuloendothelial System
  9. Plasma cell leukemia: genomic features and their potential relevance for exploring clinical actionability
    Meera Mohan, Natalie A. Danziger, Othman Salim Akhtar, Ravi Kishore Narra, Marcelo C. Pasquini, Sabarinath Venniyil Radhakrishnan, Binod Dhakal, Anita D’Souza, Douglas I. Lin, Caleb Ho et al. · 2025 · Blood Advances
  10. Clonal evolutionary analysis reveals patterns of malignant transformation of Intraductal Papillary Mucinous Neoplasms of the pancreas
    Antonio Pea, Xiaotong T. He, Rosie Upstill-Goddard, Claudio Luchini, Leonor Patricia Schubert Santana, Stephan B. Dreyer, Fraser Duthie, Nigel Balfour Jamieson, Colin J. McKay, Euan J. Dickson et al. · 2026 · Nature Communications
  11. Outpatient Delivery of Step‐Up Doses to Rapidly Initiate Monthly Doses of Bispecific Antibodies in Multiple Myeloma
    Aline G. Ramírez-Alvarado, Ana Laura Varela-Constantino, David Gómez‐Almaguer, Roberto Ovilla-Martínez, Martha Alvarado‐Ibarra, Fernando Pérez-Zincer, Christian Ramos‐Peñafiel, Diego Cruz, Manuel Solano-Genesta, María del Carmen López-Sánchez et al. · 2026 · European Journal Of Haematology
  12. Increasing genomic discovery in newly diagnosed multiple myeloma: defining disease biology and its correlation to risk
    Patrick Hagen, Mark Sellin, Stephanie Berg, Jiwang Zhang · 2022 · Annals of Hematology
  13. Simultaneously Targeting Two Coupled Signalling Molecules in the Mesenchymal Stem Cell Support Efficiently Sensitises the Multiple Myeloma Cell Line H929 to Bortezomib
    Rojas Zambrano Paula‐Manuela, J. E. Meyer-Herrera, Paola Fernanda Ruiz-Aparicio, Jean‐Paul Vernot · 2023 · International Journal of Molecular Sciences
  14. Retreatment of multiple myeloma with previously refractory drugs
    Utkarsh Goel, Charalampos Charalampous, Prashant Kapoor, Moritz Binder, Francis K. Buadi, David Dingli, Angela A. Dispenzieri, Amie L Fonder, Morie Abraham Gertz, Wilson I. Gonsalves et al. · 2024 · Blood Advances
  15. Transformation of mature mouse B cells into malignant plasma cells in vitro via introduction of defined genetic elements
    Kari Högstrand, Jessica Margareta Lindvall, Anne Sundblad, Alf Grandien · 2019 · European Journal of Immunology
  16. MOLECULAR GENETIC STRUCTURE OF MULTIPLE MYELOMA TUMOUR CELLS PRIOR TO TREATMENT AND AT THE TIME OF RELAPSE: SHORT REVIEW AND CASE REPORT
    Anna Sergeeva, T. V. Abramova, В. Л. Сурин, Т. Н. Обухова, М В Довыденко, М. В. Сунцова, Anton A. Buzdin, Л. П. Менделеева · 2019 · Гематология и трансфузиология
  17. From Multiple Myeloma to Acute Myeloid Leukemia: A Case Report of a 61-year-old Woman after 8 Years of Chemotherapy and Immunotherapy
    Xue-Hang Fu, Rong-Yan Guan, Zoufang Huang, Yun Li, Guang Lu, Wei-Wei Mou, Jun Du · 2023 · Recent Patents on Anti-Cancer Drug Discovery
  18. Approach to High-Risk Multiple Myeloma
    Xiaoyi Chen, Gaurav Varma, Faith E. Davies, Gareth John Morgan · 2024 · Hematology/Oncology Clinics of North America
  19. Single-Cell RNA Sequencing before and after Light Chain Escape Reveals Intrapatient Multiple Myeloma Subpopulations with Divergent Osteolytic Gene Expression
    Denis J. Ohlstrom, Zachary J. Walker, Abhishek Pandey, Lorraine N. Davis, Krysta L. Engel, Zenggang Pan, Peter A. Forsberg, Tomer Martin Mark, Austin E. Gillen, Daniel W. Sherbenou · 2024 · Cancer Research Communications
  20. SP140 represses specific loci by recruiting polycomb repressive complex 2 and NuRD complex
    Simone Tamburri, Chiara Zucchelli, Vittoria Matafora, Ettore Zapparoli, Zivojin Jevtic, Francesco Farris, Fabio Iannelli, Giovanna Musco, Angela Bachi · 2024 · Nucleic Acids Research
  21. Novel drug combinations for newly diagnosed multiple myeloma: how can we improve on current regimens?
    Sofía I. Quezada-Ramírez, Luz C. Tarin-Arzaga, Andrés Gómez‐De León, David Gómez‐Almaguer · 2025 · Expert Review of Hematology
  22. Recommend upfront consolidation with high-dose melphalan and autologous stem cell support
    Gunjan L. Shah, Sergio Giralt · 2016 · Seminars in Oncology
  23. Combined Selection System to Lower the Cutoff for Plasma Cell Enrichment Applied to iFISH Analysis in Multiple Myeloma
    Cristina Mansilla, Elena Soria, Miren Vallejo, Alberto Valiente, Aranzazu Pérez-Juana-del-Casal, Amaya Zabalza, Guillermina Hurtado, Francisco Sala, Natalia Ramírez · 2018 · Translational Oncology
  24. Neurofibromatosis type I and multiple myeloma coexistence: A possible link?
    Fabrizio Accardi, Valentina Marchica, Cristina Mancini, Elena Maredi, Costantina Racano, Laura Notarfranchi, Davide Martorana, Paola Storti, Eugenia Marta Martella, Benedetta Dalla Palma et al. · 2018 · Hematology Reports
  25. A comprehensive targeted panel of 295 genes: Unveiling key disease initiating and transformative biomarkers in multiple myeloma
    Vivek Ruhela, Ritu Gupta, Rupin Oberoi, Anubha Gupta · 2025 · Computers in Biology and Medicine
  26. Integration of Genomics Into Treatment: Are We There Yet?
    Gareth John Morgan, John R Jones · 2017 · American Society of Clinical Oncology Educational Book
  27. Genetic convergence of rare lymphomas
    Jennifer R. Shingleton, Sandeep S. Davé · 2018 · Current Opinion in Hematology
  28. Conventional and Molecular Cytogenomic Basis of Hematologic Malignancies
    Vesna Najfeld · 2017 · Elsevier eBooks
  29. ROBO1 p.E280* Loses the Inhibitory Effects on the Proliferation and Angiogenesis of Wild-Type ROBO1 in Cholangiocarcinoma by Interrupting SLIT2 Signal
    Tao Zhou, Yaodong Zhang, Yananlan Chen, Jijun Shan, Jifei Wang, Yirui Wang, Jiang Chang, Wangjie Jiang, Ruixiang Chen, Ziyi Wang et al. · 2022 · Frontiers in Oncology
  30. Mature B‐ and T‐cell neoplasms and Hodgkin lymphoma
    Reiner Siebert, Sietse Aukema · 2015 · Wiley eBooks
  31. Multi-regional characterisation of renal cell carcinoma and microenvironment at single cell resolution
    Ruoyan Li, John R. Ferdinand, Kevin W. Loudon, Georgina Bowyer, Lira Mamanova, Joana Briosa Neves, Liam Bolt, Eirini Sofia Fasouli, Andrew R. J. Lawson, Matthew D. Young et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  32. The molecular basis of haematological malignancies
    Meng Wang, Niccolò Bolli, George S. Vassiliou · 2025 · Wiley eBooks
  33. Identification of Immunoglobulin Gene Rearrangement Biomarkers in Multiple Myeloma through cfDNA-Based Liquid Biopsy Using tchDNA-Seq
    Natalia Buenache, Andrea Sánchez-delaCruz, Isabel Cuenca, Alicia Giménez, Laura Moreno, Joaquín Martínez‐López, Juan Manuel Rosa-Rosa · 2023 · Cancers
  34. Proceedings from the First Onco Summit: LATAM Chapter, 19–20 May 2023, Rio de Janeiro, Brazil
    Vânia Hungria, Anna Maria Sureda, Garcia Campelo, Marco Aurélio Salvino, Karthik Ramasamy · 2024 · Cancers
  35. How High Quality Rice Shapes Repeat Purchases and Word of Mouth: The Role of Value and Satisfaction
    Diana Fajarwati, Holby Boy Martua Manurung, Unggul Kustiawan, Puspita Chairun Nisa · 2024 · EKOMA Jurnal Ekonomi Manajemen Akuntansi
  36. A rare case of multiple myeloma with double translocations: t(11;14) and t(14;16)
    Mina Meseha, Vishw Patel, Kirolos Sekla, Ping Yang, David Glen Coffey · 2025 · Journal of Hematopathology
  37. Liquid Biopsy as a Means of Assessing Prognosis and Identifying Novel Risk Factors in Multiple Myeloma
    Maiia V. Soloveva, Maksim Valerevich Solovev, Igor Yakutik, Бидерман Белла Вениаминовна, Elena Nikulina, Natalya Risinskaya, Т. Н. Обухова, Maria Gladysheva, Alla Mikhailovna Kovrigina, Yulia A. Chabaeva et al. · 2025 · International Journal of Molecular Sciences
  38. KRAS, NRAS, BRAF genes mutations in tumor cells of various localizations and their impact on the treatment outcomes of patients with multiple myeloma
    Maiia V. Soloveva, Maksim Valerevich Solovev, Igor Yakutik, Бидерман Белла Вениаминовна, Anastasia V. Popova, Natalya Risinskaya, Elena Nikulina, Т. Н. Обухова, Andrey Borisovich Sudarikov, Л. П. Менделеева · 2025 · Oncohematology
  39. Genetic Evidence against Clonotypic B Lymphocytes as a Reservoir for Plasma-cell Cancers
    Carmen Gonzalez, Juan‐José Garcés, Hector Gracia, Camila Guerrero, Mattia D’Agostino, Alejandro Medina-Herrera, Mario Nuvolone, Noemí Puig, María‐Teresa Cedena, Marta Lasa et al. · 2026 · Blood Cancer Discovery
  40. Dynamic cytogenetic evolution in multiple myeloma: prognostic implications from diagnosis to first relapse
    Qi Chen, Tian Tian, Y. Eric Shi, Xuxing Shen, H R Qiu, Yuanyuan Jin, Lijuan Chen, R H Guo · 2026 · The Oncologist
  41. The Evolving Role of Genomic Technologies in Multiple Myeloma: Implications for Diagnosis, Risk Stratification and Resistance
    Klára Baďurová, Veronika Kapustová, Jana Kotulová, Vítězslav Brinsa, Lenka Piherová, Václav Janoušek, Michal Pohludka, Michal Richtář, Tomáš Jelínek, Roman Hájek et al. · 2026 · Molecular Diagnosis & Therapy
  42. How Laboratory Innovations Are Shaping the Future of Multiple Myeloma Care
    Joana Caetano, Ana Marta Pires, Carlos M. A. Costa, Rui Bergantim, Adriana Isabel Roque, Patrícia Ferraz, Maria Rosário Cunha, Niccolò Bolli, Noemí Puig, Cristina M. Joao · 2026 · Cancers
  43. A detailed methodology for developing and applying a 3D polyHIPE scaffold to model myeloma cell dormancy in vitro
    Alexandria R. Sprules, Caitlin E. Jackson, Mina Aleemardani, Caitlin S. Ryan, Frederik Claeyssens, Alanna C. Green, Michelle Anne Lawson · 2026 · F1000Research
  44. The Shape-Shifting Myeloma: Adaptive Plasticity as a Hallmark of Relapse and Refractoriness
    Maria Elisa Nasso, Adele Bottaro, Demetrio Gabriele Gerace, Sabina Russo, Donato Mannina, Alessandro Allegra · 2026 · Cancers
  45. MRD dynamics predicts progression and reveals a vulnerable state for immunotherapy interception in multiple myeloma
    Carmen González, Camila Guerrero, Marta Larráyoz, Aintzane Zabaleta, Junfei Zhao, Ioannis V. Kostopoulos, Ourania Tsitsilonis, Evangelos Terpos, Norma Carmen Gutierrez, Manuela Fernández et al. · 2026 · Blood
  46. Detection of Circulating Plasma Cells in Multiple Myeloma with Extramedullary Plasmacytoma
    Jing Wang, Shuang Geng, Yuping Zhong, Mingyi Chen, Wenming Wang, Yuhong Pang, Jiajia Zhang, Yuanyuan Liu, Yanyi Huang, Hongmei Jing · 2015 · Blood
  47. Molekuláris citogenetikai vizsgálatok Baranya és Tolna megye plazmasejtes myelomában szenvedő betegein
    Szabolcs Kosztolányi, Bálint Horváth, Diána Hosnyánszki, László Kereskai, Erzsébet Sziládi, Pál Jáksó, Hussain Alizadeh, Károly Szuhai, Donát Alpár, Béla Kajtár · 2019 · Orvosi Hetilap
  48. Applications of noncoding ribonucleic acids in multiple myeloma patients
    Simone Zocchi, Antoine David, Michèle Goodhardt, David Garrick · 2022 · Elsevier eBooks
  49. Pathophysiology
    Hervé Avet‐Loiseau, Jill Corre · 2015 · Springer eBooks
  50. BDL-SP: A Bio-inspired DL model for the identification of altered Signaling Pathways in Multiple Myeloma using WES data.
    Vivek Ruhela, Lingaraja Jena, Gurvinder Kaur, Ritu Gupta, Anubha Gupta · 2023 · PubMed Central
  51. Tumor evolution during chemotherapy
    Beatrice Garavaglia, Letizia Vallino, Alessandra Ferraresi, Danny N. Dhanasekaran, Ciro Isidoro · 2024 · Elsevier eBooks
  52. Current Strategy and Principles of Multiple Myeloma Treatment: A Literature Review
    Александр Сергеевич Лучинин, Anna Semenova, С. В. Семочкин · 2025 · Clinical oncohematology
  53. Deep sequencing of the X chromosome reveals the proliferation history of colorectal adenomas
    Anna Grassi, Fabio Iannelli, Matteo Cereda, Sara Volorio, Valentina Melocchi, Alessandra Viel, Gianluca Basso, Luigi Laghi, Michele Caselle, Francesca D. Ciccarelli · 2014 · Genome biology
  54. Etiologia i patogeneza szpiczaka plazmocytowego
    Elżbieta Iskierka‐Jazdzewska, Krzysztof Jamroziak · 2015 · Hematologia
  55. New Possibilities of Treatment for Relapsed/Refractory Multiple Myeloma: A Literature Review
    Ol’ga Mikhailovna Votyakova · 2017 · Clinical oncohematology
  56. Epidemiology and Pathophysiology of Multiple Myeloma
    Malin L. Hultcrantz, Gareth John Morgan, Ola Landgren · 2017 · Hematologic malignancies
  57. Detection of Cross-Sample Contamination in Multiple Myeloma Samples and Sequencing Data
    Owen Stephens, Tobias Meißner, Niels Weinhold · 2018 · Methods in molecular biology
  58. IgL Translocations for Risk Stratification in Multiple Myeloma
    Romanos Sklavenitis‐Pistofidis, Irene M. Ghobrial · 2019 · The Hematologist
  59. From Bench to Bedside
    Gareth John Morgan, Eileen Mary Boyle, Faith E. Davies · 2021 · The Cancer Journal
  60. Multiple Myeloma
    Joshua Ryan Richter · 2021 · The Cancer Journal
  61. Multiple Myeloma: Personalised Medicine Based on Pathogenesis
    Wen‐Chi Yang, Sheng-Fung Lin, Yu‐Chieh Su · 2018 · European Medical Journal
  62. Detection of new single nucleotide polymorphisms in plasma cells carcinoma (myeloma) by polymerase chain reaction–single strand conformation polymorphism and sequencing technical methods
    Sarah K. Obayes, Sabah Hassain Enayah, Shaimaa A. Al-Oubaidy, Rana Ayad Ghaleb · 2024 · Medical Journal of Babylon
  63. Zinc finger protein 180 induces an apoptotic phenotype by activating METTL14 transcriptional activity in colorectal cancer
    Liang Xu, Xijie Chen, Qian Yan, Xin-Tao Lei, Hailing Liu, Jingping Xu, Wei-Te Shang, Jinglin Huang, Zhiting Chen, Xiaoli Tan et al. · 2024 · Oncology Reports
  64. Identification of novel tumor predisposition families and underlying genetic defects
    Mervi Aavikko · 2014 · Työväentutkimus Vuosikirja
  65. Targeting the PD-1/PD-L1 pathway potentiates immunoediting and changes the dynamics of neutral evolution in a mouse model of colorectal cancer
    Mirjana Efremova, Victoria Klepsch, Pornpimol Charoentong, Francesca Finotello, Dietmar Rieder, Hubert Hackl, Natascha Hermann‐Kleiter, Martin Löwer, Gottfried Baier, Anne Krogsdam et al. · 2017 · bioRxiv (Cold Spring Harbor Laboratory)
  66. IMPROVING PRECISION IN THERAPIES FOR HEMATOLOGICAL MALIGNANCIES
    Muntasir Mamun Majumder · 2018 · Työväentutkimus Vuosikirja
  67. *K-means and Cluster Models for Cancer Signatures
    Zura Kakushadze, Willie Yu · 2017 · RePEc: Research Papers in Economics
  68. Multiple Myeloma
    Giada Bianchi, Kenneth Carl Anderson · 2015 · Wiley eBooks
  69. A Review on Therapeutic strategies of Relapsed and Refractory Multiple Myeloma
    Dattatreya Mukherjee · 2021
  70. The genome of IMiD-refractory myeloma
    Alessandro Laganà · 2023 · Blood
  71. SNaPshot as a Valuable Option for the Identification of Mutations in Myeloma
    Jérôme Moreaux · 2014 · EBioMedicine
  72. Therapy for Multiple Myeloma – Quo Vadis?
    Leo Rasche, Klaus Martin Kortuem, Hermann Einsele, Consultant Physician, Consultant Physician · 2015 · European Oncology & Haematology
  73. The Impact of Genomics on Targeted Therapy in Multiple Myeloma and Lymphomas
    Jens G. Lohr, Birgit Knoechel · 2015 · Wiley eBooks
  74. The Molecular Basis of Haematological Malignancies
    Niccolò Bolli, George S. Vassiliou · 2015 · Wiley eBooks
  75. Università degli Studi di Milano Scuola di Dottorato in Medicina Molecolare
    Silvano Bòsari · 2012
  76. Prädiktive molekularpathologische Stratifizierung hämatologischer Neoplasien
    Mindaugas Andrulis · 2016 · Der Pathologe
  77. Tumor subclone structure reconstruction with genomic variation data
    Yi Qiao · 2014
  78. Monoclonal gammopathy of undetermined significance : natural course and comorbidities
    Ebba K. Lindqvist · 2016 · Figshare
  79. Investigação das quinases Aurora A e Aurora B na tumorigenicidade mediada pelo oncogene KRAS
    Edmilson Ozorio dos Santos · 2017 · Digital Library of Theses and Dissertations (Universidade de São Paulo)
  80. Prognosis of Myeloma/Genetics of Myeloma
    Sébastien Robiou-du-Pont, Jill Corre, Hervé Avet‐Loiseau · 2017 · Springer eBooks
  81. Monoclonal Gammopathy of Undetermined Significance
    Malin L. Hultcrantz, Ola Landgren · 2017 · Springer eBooks
  82. Single-cell exomes in an index case of amp1q21 multiple myeloma reveal more diverse mutanomes than the whole population
    Dean J. Bryant, William Tapper, Nicola J. Weston-Bell, Arnold Bolomsky, Li Song, Shengtao Xu, Andrew R Collins, Niklas Zojer, Surinder Singh Sahota · 2018 · Blood
  83. Therapeutic Targets and Signaling Pathways for Diagnosis of Myeloma
    Zeeshan Ansar Ahmed, Ashgar Nasir, Muhammad Shariq Shaikh, Tariq Moatter, Afshan Asghar Rasheed · 2019 · IntechOpen eBooks
  84. Biologie du myélome multiple : utilité clinique
    Hervé Avet‐Loiseau · 2018 · Bulletin de l Académie Nationale de Médecine
  85. WITHDRAWN: Evolutionary Game Dynamics and Cancer
    Jorge M. Pacheco, Simon A. Levin, David Dingli · 2019 · Trends in cancer · Retracted
  86. [Targeting BCMA in multiple myeloma using chimeric antigen receptor-engineered T cells].
    Mengjun Zhong, Yingxi Xu, Haiyan Xing, K J Tang, Z Tian, Qing Rao, M Wang, J X Wang · 2019 · PubMed Central
  87. BRAF-Inhibitoren in der Therapie des multiplen Myeloms
    A. Kunze, Nicola Giesen, Marc Steffen Raab · 2020 · Der Onkologe
  88. Genomic instability in Multiple Myeloma-relevance for Clinical Outcome and Efficacy of Therapy
    Fumou Sun, Yan Cheng, Siegfried Janz · 2019 · Blood and Genomics
  89. Deep sequencing as an approach to understanding the complexity and improving the treatment of multiple myeloma
    Louis S. Williams, Jessica Caro, Beatrice M. Razzo, Eileen Mary Boyle, Gareth John Morgan · 2020 · Expert Review of Precision Medicine and Drug Development
  90. Biological and Translational Considerations regarding the Recent Therapeutic Successes and Upcoming Challenges for Multiple Myeloma
    Constantine S. Mitsiades · 2020 · Cold Spring Harbor Perspectives in Medicine
  91. Mutation-dependent treatment approaches for patients with complex multiple myeloma
    Foteini Theodorakakou, Meletios Athanasios Dimopoulos, Efstathios Kastritis · 2021 · Expert Review of Precision Medicine and Drug Development
  92. New insights into plasma cell differentiation and unfolded protein response in multiple myeloma: role of DEPTOR and IRE1
    Dalia Quwaider · 2020
  93. [Progress in clonal evolution of multiple myeloma].
    Yan Wang, G An, L. Qiu · 2021 · Europe PMC (PubMed Central)
  94. Clinical features of the disease course in patients with solitary plasmacytoma and extramedullary multiple myeloma
    Ж. М. Козич, В. Н. Мартинков, Ж.Н. Пугачева, Michail Zhandarov, Л. А. Смирнова · 2020 · Health and Ecology Issues
  95. Computational and systems biology of cancer
    David Dingli · 2020 · Computational and Systems Oncology
  96. The Dynamics of Nucleotide Variants in the Progression from Low–Intermediate Myeloma Precursor Conditions to Multiple Myeloma: Studying Serial Samples with a Targeted Sequencing Approach
    Bénedith Oben, Charlotte Cosemans, Ellen Geerdens, Loes Linsen, Kimberly Vanhees, Brigitte Maes, Koen Theunissen, Bert Cruys, Marta Lionetti, Ingrid Arijs et al. · 2022 · Cancers
  97. Targeting pro-survival cell signaling pathways in multiple myeloma
    Ingrid Spaan · 2022
  98. Abnormally differentiated bone marrow mesenchymal stem cells develop into tumors in rats
    Hongxia Yuan, Shiqi Liao, Jiayu Zeng, Xiaojuan Huang, Jieyu Zhang, Jing Zhao, Yuxian Wang, Hong Zhang, Xiaoqi Wang, Shidong Liao et al. · 2018 · Translational Cancer Research
  99. Diagnosis and treatment of multiple myeloma in Hunan Province.
    Feiyang Liu, Qian Cheng, Kui Song, Huan Yu, Junjun Li, Hui Zhang, Guoyu Hu, Ming Dong Zhou, Jun Wang, Zhongqi Ding et al. · 2022 · PubMed Central
  100. Plasma Cell Disorders
    Andrew Jenho Yee, Teru Hideshima, Noopur S Raje, Kenneth Carl Anderson · 2022 · Wiley eBooks